Referencia | Nombre | Unidad | Proveedor | Aplicacion | Clonalidad | Huésped | Reactividad | Precio | Hoja Técnica |
---|---|---|---|---|---|---|---|---|---|
abx831255 | Nivolumab | 100 µg 1 mg | Abbexa | ELISA, WB | Monoclonal | Human | Solicitar Precio | Solicitar | |
abx395141 | Nivolumab ELISA Kit | 96 tests | Abbexa | ELISA | Solicitar Precio | Solicitar | |||
KA6834 | Nivolumab (Human) ELISA Kit (Quantitative) | 1 Kit | Abnova | Solicitar Precio | Solicitar | ||||
Ab00791-10.0-BT | Anti-PD-1 [5C4.B8 (Nivolumab)] | 1 mg | Absolute Antibody | IHC; FC; SPR; block | Human; cynomolgus | Solicitar Precio | Solicitar | ||
Ab00791-10.0 | Anti-PD-1 [5C4.B8 (Nivolumab)] | 100 ug | Absolute Antibody | IHC; FC; SPR; block | Human; cynomolgus | Solicitar Precio | Solicitar | ||
Ab00791-13.12 | Anti-PD-1 [5C4.B8 (Nivolumab)] | 200 ug | Absolute Antibody | IHC; FC; SPR; block | Human; cynomolgus | Solicitar Precio | Solicitar | ||
Ab00791-15.0 | Anti-PD-1 [5C4.B8 (Nivolumab)] | 50 ug | Absolute Antibody | IHC; FC; SPR; block | Human; cynomolgus | Solicitar Precio | Solicitar | ||
Ab00791-23.0 | Anti-PD-1 [5C4.B8 (Nivolumab)] | 200 ug | Absolute Antibody | IHC; FC; SPR; block | Human; cynomolgus | Solicitar Precio | Solicitar | ||
Ab00791-15.0-BT | Anti-PD-1 [5C4.B8 (Nivolumab)] | 500 ug | Absolute Antibody | IHC; FC; SPR; block | Human; cynomolgus | Solicitar Precio | Solicitar | ||
Ab00791-21.0 | Anti-PD-1 [5C4.B8 (Nivolumab)] | 50 ug | Absolute Antibody | IHC; FC; SPR; block | Human; cynomolgus | Solicitar Precio | Solicitar | ||
Ab00791-1.1 | Anti-PD-1 [5C4.B8 (Nivolumab)] | 200 ug | Absolute Antibody | IHC; FC; SPR; block | Human; cynomolgus | Solicitar Precio | Solicitar | ||
Ab00791-23.0-BT | Anti-PD-1 [5C4.B8 (Nivolumab)] | 1 mg | Absolute Antibody | IHC; FC; SPR; block | Human; cynomolgus | Solicitar Precio | Solicitar | ||
Ab00791-21.0-BT | Anti-PD-1 [5C4.B8 (Nivolumab)] | 500 ug | Absolute Antibody | IHC; FC; SPR; block | Human; cynomolgus | Solicitar Precio | Solicitar | ||
Ab00791-1.1-BT | Anti-PD-1 [5C4.B8 (Nivolumab)] | 1 mg | Absolute Antibody | IHC; FC; SPR; block | Human; cynomolgus | Solicitar Precio | Solicitar | ||
Ab00791-13.12-BT | Anti-PD-1 [5C4.B8 (Nivolumab)] | 1 mg | Absolute Antibody | IHC; FC; SPR; block | Human; cynomolgus | Solicitar Precio | Solicitar | ||
BN164047 | Nivolumab - >10 mg/ml | 1mg 2mg 5mg 10mg 25mg | Biosynth | Solicitar Precio | Solicitar | ||||
SIM0003-25MG | InVivoSIM anti-human PD-1 (Nivolumab Biosimilar) | 25 mg | BioXCell | Blocking of PD-1/PD-L signaling, Flow Cytometry, I | Human | Human | Solicitar Precio | Solicitar | |
SIM0003-100MG | InVivoSIM anti-human PD-1 (Nivolumab Biosimilar) | 100 mg | BioXCell | Blocking of PD-1/PD-L signaling, Flow Cytometry, I | Human | Human | Solicitar Precio | Solicitar | |
SIM0003-50MG | InVivoSIM anti-human PD-1 (Nivolumab Biosimilar) | 50 mg | BioXCell | Blocking of PD-1/PD-L signaling, Flow Cytometry, I | Human | Human | Solicitar Precio | Solicitar | |
SIM0003-1MG | InVivoSIM anti-human PD-1 (Nivolumab Biosimilar) | 1 mg | BioXCell | Blocking of PD-1/PD-L signaling, Flow Cytometry, I | Human | Human | Solicitar Precio | Solicitar | |
SIM0003-5MG | InVivoSIM anti-human PD-1 (Nivolumab Biosimilar) | 5 mg | BioXCell | Blocking of PD-1/PD-L signaling, Flow Cytometry, I | Human | Human | Solicitar Precio | Solicitar | |
GS40478 | (Nivolumab)Biosimilar Reference Antibody(PDCD1/CD279/PD1) | 100uL, 10mg, 100mg | Mabnus | ELISA,IF; Recommended dilution: WB:1:5000, IF:1:50 | Genetically human | Human | Solicitar Precio | Solicitar | |
10-496 | Nivolumab (PDCD1/PD1/CD279) - Research Grade Biosimilar | 0.1 mg | ProSci | Recombinant | Solicitar Precio | Solicitar | |||
52899 | Anti-PD-1 [Nivolumab] | 5mg | Signalway | WB | Solicitar Precio | Solicitar |